CTC Alternative Strategies »

Alnylam Pharmaceuticals shares owned by CTC Alternative Strategies

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by CTC Alternative Strategies from 13F filings

Historical chart of CTC Alternative Strategies investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by CTC Alternative Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by CTC Alternative Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $682k 1.5k 456.00

More positions owned by CTC Alternative Strategies

Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Select Sector Spdr Tr Indl (XLI)
Coinbase Global Com Cl A (COIN)
Mizuho Financial Group Sponsored Adr (MFG)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Select Sector Spdr Tr Sbi Materials (XLB)
Strategy Cl A New (MSTR)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pepsi (PEP)
American Express Company (AXP)
Kimberly-Clark Corporation (KMB)

View all positions for CTC Alternative Strategies

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals